E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/5/2009 in the Prospect News PIPE Daily.

New Issue: China Biologic plans $9.55 million placement of 3.8% convertible notes

By Susanna Moon

Chicago, June 5 - China Biologic Products, Inc. agreed to issue $9.55 million principal amount of 3.8% senior secured convertible notes.

Interest is payable semiannually. Beginning Sept. 30, the company may pay accrued interest through the issuance of common shares.

Investors also will receive warrants to purchase up to 1,194,268 common shares. Each warrant is exercisable at $4.80 per share for three years.

The notes are putable upon four weeks' written notice at par plus two years of interest payments in some instances.

China Biologic is a biopharmaceutical company based in Taian City, China.

Issuer:China Biologic Products, Inc.
Issue:Senior secured convertible notes
Amount:$9,554,140
Coupon:3.8%
Price:Par
Yield:3.8%
Warrants:For up to 1,194,268 shares
Warrant expiration:Three years
Warrant strike price:$4.80
Pricing date:June 5
Stock symbol:OTCBB: CBPO
Stock price:$4.75 at close June 4

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.